These two companies are among the biggest generic producers in the world. It is very troubling that quality control measures fails so often in their production. All of these failures should have been caught before the products went to market. A recall should have been unnecessary. When industry leaders like Ranbaxy and Actavis fails so miserably, is this an indication that there is a systemic problem in the entire industry?

The newly elected government of Thailand is continuing the policy of the previous government’s disregard for international patent law and the health of their citizens. Now the Thai Minister of Health is proposing that the government “ignore” four cancer medicine patents, and start domestic, unlicenced production. The military dictatorship this government replaced a few months [...]